Skip to main content
. 2021 Jun 9;11:12180. doi: 10.1038/s41598-021-91852-6

Figure 2.

Figure 2

Adjustment of age, sex, calendar year, and comorbidities at diagnosis for lead-time bias. A patient with stage IV adenocarcinoma is routinely diagnosed at a mean age of 68.4 (see Table 2). If the patient was diagnosed earlier at stage IA (at a mean age of 66.3), the average gain in life expectancy (LE) would be 14.5–1.9 = 12.6 years. However, if we take different age, sex, year of diagnosis, and comorbidities into consideration and compared the loss-of-LE, the average savings of loss-of-LE would be 15.1–3.7 = 11.4 years, which implies an adjustment for lead-time bias. The values in parentheses for age and LE/loss-of-LE denote the standard deviations and 95% confidence intervals, respectively. † denotes mortality. BAC bronchioloalveolar carcinoma.